AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

RM PLC

Board/Management Information Feb 3, 2020

5284_rns_2020-02-03_d959ed7e-555a-49fe-a7ce-03e7cfd1db77.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7946B

RM PLC

03 February 2020

3 February 2020

RM plc

("RM")

BOARD APPOINTMENTS

RM is pleased to announce that Paul Dean has been appointed a Non-Executive Director and Chair of the Audit Committee, with effect from 4 February 2020.

Mr. Dean is currently Non-Executive Director and Chair of the Audit Committee for Wincanton plc and Focusrite plc, and the Senior Independent Director and Chair of the Audit Committee of Polypipe plc.  On 3 February 2020, he will retire as the Senior Independent Director and Chair of the Audit Committee Chair at Porvair after 7 years. 

He was previously Group Finance Director of Ultra-Electronics plc from 2008 to 2013 and Group Finance Director of Foseco plc from 2005 to 2008.   

There are no further details relating to Paul Dean that require disclosure under Rule 9.6.13 of the Listing Rules.

Deena Mattar will retire as Chairman of the Audit Committee on 4 February 2020 and as a Director later in the year having completed 9 years of service as a Director.

Contacts:

RM plc

David Brooks, Chief Executive Officer                               08450 700300

Neil Martin, Chief Financial Officer

Headland Consultancy                                                 020 3805 4822

Stephen Malthouse

Abena Affum

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAFLFIEFFIVIII

Talk to a Data Expert

Have a question? We'll get back to you promptly.